Gyawali, Bishal <br/><br/>
Information Transparency in the Drug Approval Process-Reply.  [electronic resource] 

 -  JAMA oncology  11 2018 
 - 1622 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2018.4163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Renal Cell<br/>Drug Approval<br/>Humans<br/>Kidney Neoplasms<br/>Sunitinib<br/>United States Food and Drug Administration